Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Other financing activities (2024)

Coya Therapeutics (COYA) has disclosed Other financing activities for 1 consecutive years, with $11250.0 as the latest value for Q1 2024.

  • Quarterly Other financing activities changed N/A to $11250.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $11250.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $11250.0 for FY2024, N/A changed from the prior year.
  • Other financing activities hit $11250.0 in Q1 2024 for Coya Therapeutics.
  • In the past five years, Other financing activities ranged from a high of $11250.0 in Q1 2024 to a low of $11250.0 in Q1 2024.